Observational studyJournal of the American Academy of Dermatology2015

OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results.

Alexa B Kimball et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.